This internationally renowned author team provides a unique and thorough analysis and distillation of the endocannabinoid system and its relationship to abdominal obesity, diabetes, and cardiovascular disease. The endocannabinoid system (ECS) plays an important role in cardiometabolic risk, as well as modulating energy balance, feeding behavior, hepatic lipogenesis, and perhaps glucose homeostasis. Evidence suggests that the ECS is overactive in human obesity and dyslipidemia.

Critical to the management of cardiometabolic risk, this new, timely book provides practical overviews and management guidance on many important topics, including:

• abdominal obesity and the metabolic syndrome
• the endocannabinoid system and energy balance: functions and dysfunctions
• abdominal obesity, the EC system, and cardiometabolic risk